6-Minute Explainer — “Ivermectin Dosage Levels in Cancer Research”

🧩 What You’ll Learn

In this 6-minute educational video, we break down Dr. William Makis MD’s overview of ivermectin dosage levels in cancer research, explaining each tier and its scientific context:

✅ The four commonly discussed dosage levels (≤0.5 mg/kg → ≥2.5 mg/kg)
✅ Publicly reported physician case studies and observations
✅ Educational context for remission, maintenance, and aggressive diseases
✅ Safety notes, potential side effects, and limitations of available data

⏱️ Chapters

00:00 – Introduction & Disclaimer
00:40 – Low Dose (≤0.5 mg/kg)
01:40 – Medium Dose (1.0 mg/kg)
02:40 – High Dose (2.0 mg/kg)
03:40 – Very High Dose (≥2.5 mg/kg)
05:00 – Reported Case Studies & Notes
05:45 – Safety & Final Reminder

ORDER HERE :- PharmacyinUSA.com

📊 Overview of the Four Dosage Levels

🟢 Low Dose (≤ 0.5 mg/kg)

Typically discussed in educational sources as a maintenance or remission-support range.
Some reports describe it being explored for preventive or adjunct contexts.
No clinical endorsement — for informational study purposes only.

🟡 Medium Dose (≈ 1.0 mg/kg)

Referenced in several case discussions as a baseline educational reference for ongoing research.
Used to illustrate possible dose-response trends in academic reviews.

🔴 High Dose (≈ 2.0 mg/kg)

Appears in limited case reports involving aggressive or advanced disease scenarios.
All data remain anecdotal; formal trials are required to validate findings.

🔵 Very High Dose (≥ 2.5 mg/kg)

Occasionally noted in discussions surrounding late-stage or brain cancers.
Reported side effects include temporary visual changes or fatigue in anecdotal cases.
Such doses are experimental and must not be attempted without clinical oversight.

ORDER HERE :- PharmacyinUSA.com

🧠 Reported Case Notes & Observations

The video highlights public case notes and physician commentaries shared by professionals such as Dr. Tess Lawrie, Dr. Shankara Chetty, and Dr. Allan Landrito.
These insights are referenced for education only to illustrate how dosage levels are discussed in scientific and advocacy contexts.
Each report has limitations — differences in patient health, concurrent therapies, and small sample sizes.

For accurate evaluation, readers should rely on peer-reviewed research and official medical guidance.

⚕️ Safety Notes & Limitations

  • Understand potential drug interactions and contraindications.

  • Side effects may include dizziness, gastrointestinal upset, or mild neurological effects depending on dose and health status.

🌐 Order here (Guaranteed Delivery USA & EUROPE)

For health-related educational materials and quality products, visit

ORDER HERE :- PharmacyinUSA.com

Follow our updates for more professional overviews of repurposed therapeutics, dosage education, and research awareness.